Borosil Scientific Limited — Others, 18-07-2025: Shareholders meeting

Borosil Scientific has announced its upcoming Annual General Meeting, where it will present strong financial results for FY2024-25. Consolidated revenue hit ₹438.49 Cr with PAT at ₹26.72 Cr. Operationally, the company saw robust growth in Laboratory Instrumentation (up 32.3%) and Process Systems (up 17.8%), alongside solid Pharma Packaging sales of ₹68.5 Cr. The board plans to seek shareholder approval for re-appointing directors and raising up to ₹250 Cr to fuel future organic and inorganic growth initiatives. Related party transactions will also be discussed.